Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer
Metabolites · 24.03.2025 · 15 (4) · 221
DOI: 10.3390/metabo15040221 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 24.03.2025. Verfasst von Salvatore Zarrella und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 373 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell’Università e della Ricerca (MIUR).
Abstract (Originalsprache)
Background/Objectives: Endoplasmic reticulum (ER) stress occurs when ER homeostasis is disrupted, leading to the accumulation of misfolded or unfolded proteins. This condition activates the unfolded protein response (UPR), which aims to restore balance or trigger cell death if homeostasis cannot be achieved. In cancer, ER stress plays a key role due to the heightened metabolic demands of tumor cells. This review explores how metabolomics can provide insights into ER stress-related metabolic alterations and their implications for cancer therapy.
Methods
A comprehensive literature review was conducted to analyze recent findings on ER stress, metabolomics, and cancer metabolism. Studies examining metabolic profiling of cancer cells under ER stress conditions were selected, with a focus on identifying potential biomarkers and therapeutic targets.
Results
Metabolomic studies highlight significant shifts in lipid metabolism, protein synthesis, and oxidative stress management in response to ER stress. These metabolic alterations are crucial for tumor adaptation and survival. Additionally, targeting ER stress-related metabolic pathways has shown potential in preclinical models, suggesting new therapeutic strategies.
Conclusions
Understanding the metabolic impact of ER stress in cancer provides valuable opportunities for drug development. Metabolomics-based approaches may help identify novel biomarkers and therapeutic targets, enhancing the effectiveness of antitumor therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.
- NBFC, National Biodiversity Future Center, 90133 Palermo, Italy.
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 49, 80131 Napoli, Italy.
- Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Via Archirafi 28, 90123 Palermo, Italy.
ORCID-Profile: Salvatore Zarrella, Maria Rosaria Miranda, Verdiana Covelli, Ignazio Restivo, Luisa Tesoriere, Manuela Rodriquez, Pietro Campiglia, Mario Felice Tecce, Vincenzo Vestuto
Förderung
- Ministero dell’Università e della Ricerca (MIUR)
Zitieren
APA
Zarrella, S., Miranda, M. R., Covelli, V., Restivo, I., Novi, S., Pepe, G., Tesoriere, L., Rodriquez, M., Bertamino, A., Campiglia, P., Tecce, M. F., & Vestuto, V. (2025). Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer. Metabolites, 15(4), 221. https://doi.org/10.3390/metabo15040221
Vancouver
Zarrella S, Miranda MR, Covelli V, Restivo I, Novi S, Pepe G, et al. Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer. Metabolites. 2025;15(4):221. doi:10.3390/metabo15040221
BibTeX
@article{Zarrella2025,
author = {Zarrella, Salvatore and Miranda, Maria Rosaria and Covelli, Verdiana and Restivo, Ignazio and Novi, Sara and Pepe, Giacomo and Tesoriere, Luisa and Rodriquez, Manuela and Bertamino, Alessia and Campiglia, Pietro and Tecce, Mario Felice and Vestuto, Vincenzo},
title = {Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer},
journal = {Metabolites},
year = {2025},
volume = {15},
number = {4},
pages = {221},
doi = {10.3390/metabo15040221}
}
EUVIMED